18. Common Shares and Warrants Outstanding at January 31, 2010 * Proceeds are only realized if the options and warrants are exercised under the terms and conditions of the options and warrants. ** If warrants are unexercised as at August 10, 2011, holders have until February 10, 2012 to purchase 1,696,500 common shares at $1.50. All Canadian dollars unless otherwise stated Exercise Price Common Shares Potential Proceeds* (millions) Common Shares 69,089,916 Warrants Expiring August 10, 2011 2.25 13,180,500 29.6 Expiring August 10, 2011** 1.50 2,153,250 3.3 Expiring December 18, 2011 0.75 336,000 0.2 Total Warrants 15,669,750 33.1 Options Expiring August 10, 2015 0.25 737,500 0.2 Expiring August 10, 2015 0.75 3,100,000 2.3 Expiring August 19, 2015 1.85 300,000 0.6 Expiring October 18, 2015 2.28 158,333 0.3 Expiring January 14, 2016 1.96 100,000 0.2 Total Options 4,395,833 3.6 Total Fully Diluted 89,591,499 36.7
19.
20. Multiple High Grade Gold Veins Name Width Grade Depth Sheep Dip Vein 1.1 m 29.3 g/t 149.6 m 1.3 m 31.4 g/t 36.1 m Mullen Vein 1.0 m 19.3 g/t 274.0 m 1.3 m 19.6 g/t 49.9 m T-17 HW Vein 4.1 m 42.7 g/t 42.9 m 1.6 m 56.3 g/t 416.2 m T-17 Vein 3.4 m 68.1 g/t 39.6 m 1.5 m 27.0 g/t 107.0 m No. 1 Vein 2.0 m 48.7 g/t 77.0 m 1.3 m 65.7 g/t 159.8 m 106-16 Vein 2.0 m 24.0 g/t 41.5 m 3.3 m 16.9 g/t 615.7 m Road Cut Vein 1.6 m 14.1 g/t 55.5 m 1.2 m 13.9 g/t 123.1 m
25. A Golden Opportunity in Northern Ireland Patrick F. N. Anderson Chairman and Chief Executive Officer Keith McKay Chief Financial Officer Trading Symbol: DNA on TSX Executive Office: Dalradian Resources Inc. 161 Bay Street, 26th Floor Toronto, Ontario Canada M5J 2S1 www.dalradian.com Investor Relations: 416-572-2706 [email_address]